Physician profile
Wayne O Wells
NPI 1780685743
$1,919.56
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $864 · 2020: $202 · 2021: $739 · 2022: $89.84 · 2024: $25.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $868.91 | 2019-2022 | |
| Novo Nordisk INC | $157.87 | 2019-2021 | |
| Lilly USA, LLC | $156.67 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $134.75 | 2019 | |
| Glaxosmithkline, LLC. | $133.33 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.73 | 2019 | |
| Amarin Pharma, INC. | $95.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $85.67 | 2019-2020 | |
| Abbvie INC. | $52.31 | 2022 | |
| Pfizer INC. | $25.11 | 2019 | |
| Shield Therapeutics INC | $25.07 | 2024 | |
| Genentech USA, INC. | $21.26 | 2020 | |
| Indivior INC. | $18.71 | 2019 | |
| Gilead Sciences, INC. | $15.80 | 2019 | |
| Aytu Biopharma, INC. | $15.35 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $14.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.